OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

Regulation (EEC) No 2377/90 is modified as follows:

  1. A..

    Annex I is modified as follows:

    1. 2..

      Anti-parasitic agents

      1. 2.3.

        Agents acting against endo- and ectoparasites

        1. 2.3.1.

          Avermectins

          Pharmacologically active substanceMarker residueAnimal SpeciesMRLsTarget tissuesOther provisions

          ‘2.3.1.4.

          Eprinomectin

          Eprinomectin B1aBovine30 μg/kgMuscle
          30 μg/kgFat
          600 μg/kgLiver
          100 μg/kgKidney
          30 μg/kgMilk’
  2. B..

    Annex II is modified as follows:

    1. 1..

      Inorganic chemicals

      Pharmacologically active substance(s)Animal SpeciesOther provisions

      ‘1.24.

      Zinc acetate

      All food producing species

      1.25.

      Zinc chloride

      All food producing species

      1.26.

      Zinc gluconate

      All food producing species

      1.27.

      Zinc oleate

      All food producing species

      1.28.

      Zinc stearate

      All food producing species’
    2. 2..

      Organic compounds

      Pharmacologically active substance(s)Animal SpeciesOther provisions

      ‘2.69.

      Chlorhexidine

      All food producing speciesFor topical use only

      2.70.

      Glycerol formal

      All food producing species

      2.71.

      Hesperidin

      Equidae

      2.72.

      Hesperidin methyl chalcone

      Equidae

      2.73.

      Menbutone

      Bovine, ovine, caprine, porcine, equidae

      2.74.

      Quatresin

      All food producing speciesFor use as preservative only at concentrations of up to 0,5 %’
  3. C..

    Annex III is modified as follows:

    1. 1..

      Anti-infectious agents

      1. 1.2.

        Antibiotics

        1. 1.2.6.

          Quinolones

          Pharmacologically active substanceMarker residueAnimal SpeciesMRLsTarget tissuesOther provisions

          ‘1.2.6.4.

          Flumequine

          FlumequineBovine, ovine, porcine, chicken50 μg/kgMuscle, fat or fat/skinProvisional MRLs expire on 1.1.2000’
          100 μg/kgLiver
          300 μg/kgKidney
          Salmonidae150 μg/kgMuscle/skin
          1. 1.2.8.

            Tetracyclines

            Pharmacologically active substanceMarker residueAnimal SpeciesMRLsTarget tissuesOther provisions

            ‘1.2.8.1.

            Doxycycline

            Sum of parent drug and its 4-epimerPorcine, poultry600 μg/kgKidneyProvisional MRLs expire on 1.1.1998’
            300 μg/kgLiver, skin/fat
            100 μg/kgMuscle
            Bovine600 μg/kgKidney
            300 μg/kgLiver
            100 μg/kgMuscle
    2. 2..

      Antiparasitic agents

      1. 2.1.

        Agents acting against endoparasites

        1. 2.1.1.

          Benzimidazoles and pro-benzimidazoles

          Pharmacologically active substanceMarker residueAnimal SpeciesMRLsTarget tissuesOther provisions

          ‘2.1.1.10.

          Albendazole sulphoxide

          Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazoleBovine, ovine, pheasant1 000 μg/kgLiverProvisional MRLs expire on 1.1.1998’
          500 μg/kgKidney
          100 μg/kgMuscle, fat
          Bovine, ovine100 μg/kgMilk
  4. D..

    Annex IV is modified as follows:

    List of pharmacologically active substances for which no maximum levels can be fixed:

    ‘8.

    Chlorpromazine’